Clinical trial teams are under increasing pressure to deliver more statistical rigor, faster timelines, and stronger traceability. Meanwhile, designs are getting more complex with the inclusion of adaptations, Bayesian methods, and nuanced endpoints. The challenge is no longer limited to sample size and power computations. It now involves decision-making under uncertainty, and the operational complexity of finding the right balance between methodology implementation and realistic execution scenario assumptions.

AI can support trial design experts in identifying and explaining the options they should consider, drafting and reviewing code to make their design simulations more comprehensive, and eventually picking out highlights from their findings to better report their recommendations to cross-functional clinical peers. When embedded directly within trial design tools, AI assistants can combine the capabilities of the underlying software with contextual guidance while maintaining traceable citations and context aligned with regulatory standards. This consequently frees experts to focus on the decisions that drive trial quality: design trade-offs, risk mitigation, and ensuring alignment across stakeholders through clear communication.

Incorporating AI in the trial design workflow

AI tools can be leveraged by statisticians to help them create better trial designs while also saving them time in doing so.

• Learning and enablement: On-demand explanations of statistical concepts and design patterns accelerate onboarding and reduce dependency on scarce specialists for baseline questions.
• Knowledge retrieval: Fast access to regulatory guidance as well as guides on how to use available tools, which is especially helpful when information is fragmented across manuals, wikis, and repositories.
• Coding support: Drafting, explaining, and debugging scripts shortens iteration cycles in simulation and analysis.
• Design exploration: AI can structure comparisons between design options, translate simulation outputs into reports, and present trade-off summaries.
• Documentation and automation: Drafting repetitive content such as tables and descriptions of operating characteristics can reduce the time required both to prepare and review key information.

Context engineering

Reliability in this setting requires moving beyond ad hoc prompting toward context engineering. Prompting improves how you ask. Context engineering ensures the model receives the right information, in the right structure, at the right time to ensure that the outputs reflect your domain, standards, and tooling rather than generic guidance.

Key context engineering components include:

• Role and instruction setting: Clear boundaries on what the assistant should and should not do.
• Structured inputs: Consistent schemas for design requirements, endpoints, assumptions, and constraints.
• Curated examples: Demonstrations of the expected reasoning style and acceptable outputs.
• Tool access: Retrieval and workflow actions via controlled interfaces (e.g., fetch documents, run checks, generate templates).
• Stateful workflows: Persistent memory of decisions, assumptions, and where the user is in the process of designing a trial, enabling reproducible multi-step work.

A core context engineering mechanism is called retrieval-augmented generation (RAG). Instead of relying on general training knowledge, RAG systems retrieve relevant passages from trusted sources at query time (e.g., validated internal standards, product manuals, peer-reviewed references, and regulatory guidance), and inject them into the model’s context before it answers. When it is properly executed, this approach improves consistency, grounds responses in trusted information, and reduces the risk of hallucinations.

Evaluation of AI-driven tools

Even with strong context, clinical trial designs are too consequential to rely on AI tools that have not undergone rigorous testing. Systematic evaluation adds an essential assurance layer by determining whether outputs are correct, stable, grounded in approved sources, and produced using the right knowledge and context at the right time.

Effective evaluation includes:

• Defined tasks with known inputs and expected outputs
• Repeat runs to measure stability under paraphrasing and workflow variation
• Full transcripts for debugging, transparency, and auditability
• Grading methods that combine code-based checks (unit-test style validation), model-based scoring (a separate evaluator LLM model), and human review for setting benchmarks and identifying edge cases

Common metrics include correctness, completeness, adherence to guidelines and house style, retrieval quality, and hallucination rate. The goal is an iterative loop: evaluations first surface failure modes, then teams adjust retrieval, context, tool orchestration, and response constraints, and finally re-test until performance is predictable enough for production.

Product assistants

In complex software environments, users often need to navigate intricate workflows, understand domain-specific concepts, and locate the right functionality at the right time. Product assistants play an important role in simplifying this experience by providing real-time, contextual support directly within the workflow. At Cytel, we have applied this approach through Cyrus, the East Horizon™ product assistant, which provides real-time, contextual answers related to biostatistics, clinical trial design, and effective use of the East Horizon platform using trusted documentation sources. Traceability can be maintained because each answer generated by the product assistant can be tied back to the underlying source material that is found in the tool’s documentation. This is the key distinction between generic and purpose-built AI. A generic model can answer a broad range of questions, but it does not inherently understand a specific product, its terminology, or its validated documentation. A grounded product assistant is designed to operate within that context.

Coding assistants

Customization of native software functionalities can sometimes be done by incorporating code into specific elements of the software. Many platforms support overriding response models or operational assumptions with user-created code, but doing so typically requires code that matches the software’s expected interface, as well as coding experts who know how to program their needed functions. For example, variable names must match what the software would expect those parameters to be named, so even the most fluent programmers may lack this knowledge depending on which tool they are trying to connect their code with. A coding assistant can therefore reduce development time by generating simulation-ready functions aligned to specific software requirements, providing templates that expert programmers can build off. The R Code Assistant available for East Horizon, for example, can generate R code based on natural-language instructions, align it with the expected East Horizon input and output variables, and provide example calls that allow users to validate the code quickly. Users can then refine the output through follow-up instructions.

The benefit is not only speed. Coding assistants can also improve consistency, reduce dependence on a small group of programming experts, and support workflows where generated code can be reviewed, tested, versioned, and then ultimately reused by other team members.

Final takeaways

AI should not be used to replace the expertise required to design high-quality clinical trials, but to amplify it. When grounded in validated knowledge, integrated into existing workflows, and evaluated with the same rigor expected of clinical research itself, AI can help statisticians spend less time searching for information, writing repetitive code, and documenting results, and more time making the complex design decisions that increase the probability of trial success. The greatest value comes from treating AI as a trusted assistant rather than an autonomous decision-maker, enabling faster, more consistent, and more transparent trial design without compromising scientific or regulatory standards.

Share Via